UTHR FY2025 SEC EDGAR DEF 14A #55 of 168 in industry

UNITED THERAPEUTICS Corp CEO pay ratio

The CEO earned $18.0M in FY2025 against median worker pay of $237,406 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-29
Industry
Chemicals & Pharmaceuticals
Industry rank
#55/168

Data updated August 2026

Subscribe to UNITED THERAPEUTICS Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
76:1
Moderate (Scale: 0–1000:1)
CEO pay
$18.0M
Median worker
$237,406

Answer first

UNITED THERAPEUTICS Corp's FY2025 CEO total of $18.0M ranks #206 of 1,423 complete filings; its 76:1 pay ratio ranks #793. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $237,406. Industry placement uses the FY2025 SIC-28 peer cohort (# 55 of 168, 68th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#206
$18.0M of 1,423 FY2025
Ratio rank
#793
76:1 of 1,423
Industry pct
68th
above the industry median pay ratio

How UNITED THERAPEUTICS Corp ranks nationally

UNITED THERAPEUTICS Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$18,042,856 Top 14% higher than 86% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). This entry sits in this band. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

UNITED THERAPEUTICS Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($18.0M) against pay ratio (76:1) for UNITED THERAPEUTICS Corp (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both7237298.710879598.41452189818164197.721806497.340.0:150.8:161.5:172.2:183.0:1CEO total payPay ratio (CEO : median worker)UNITED THERAPEUTICS Corp, CEO total pay: 18042856 · Pay ratio (CEO : median worker): 76:1UNITED THERAPEUTICS CorpLantheus Holdings, Inc., CEO total pay: 15346066 · Pay ratio (CEO : median worker): 79:1Lantheus Holdings, Inc.Xeris Biopharma Holdings, Inc., CEO total pay: 16937606 · Pay ratio (CEO : median worker): 73:1Xeris Biopharma Holdings, Inc.Vertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / MaSupernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Chemours Co, CEO total pay: 8600301 · Pay ratio (CEO : median worker): 71:1Chemours Co
UNITED THERAPEUTICS Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in UNITED THERAPEUTICS Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · UNITED THERAPEUTICS Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
76:1
FY2025
vs prior FY
-33:1
from FY2024 109:1
CEO $ YoY
-22%
$18.0M latest
Filings shown
4
FY2022–2025
UNITED THERAPEUTICS Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $5.3M - $190,214 28:1 -
2023 $17.1M +220% $210,540 81:1 +53:1
2024 $23.0M +35% $211,298 109:1 +28:1
2025 $18.0M -22% $237,406 76:1 -33:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1082554, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
76:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$18.0M
Companies in Industry
168
vs. Industry Median
Above
#55 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

UNITED THERAPEUTICS Corp: MID · PEAK pay ratio

UNITED THERAPEUTICS Corp's FY2025 ratio 76:1 ranks #55 of 168 Chemicals & Pharmaceuticals filers (68th percentile). the CEO earned 76× the median employee ($237,406) in FY2025.

Median employee $237,406 (ELITE-MED); MID · PEAK stamps put about 76 median-wage years per CEO year.

CEO Total Pay

$18.0M

FY2025 Summary Compensation, well above median

Pay Ratio

76:1

Near industry median

UNITED THERAPEUTICS Corp in the higher Chemicals & Pharmaceuticals third

UNITED THERAPEUTICS Corp's FY2025 ratio 76:1 ranks #55 of 168 Chemicals & Pharmaceuticals filers (68th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; UNITED THERAPEUTICS Corp's $18.0M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #206 and ratio rank #793 split - treat 76:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$18.0M
Median Employee Pay
$237,406
Pay Ratio
76:1
Filing Date
2026-04-29

Company Info

Ticker
UTHR
CIK
1082554
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1082554, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. UNITED THERAPEUTICS Corp's FY2025 ratio 76:1 ranks #55 of 168 Chemicals & Pharmaceuticals filers (68th percentile).

Read with UNITED THERAPEUTICS Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.

Occidental Petroleum Corp /de/ · PEAK

ABS(ceo_total_comp) peer at $18.1M (Δ $8K heavier vs UNITED THERAPEUTICS Corp); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
GE Vernova Inc. · PEAK

ABS(ceo_total_comp) peer at $18.0M (Δ $23K lighter vs UNITED THERAPEUTICS Corp); STEEP · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Keysight Technologies, Inc. · PEAK

ABS(ceo_total_comp) peer at $18.0M (Δ $23K lighter vs UNITED THERAPEUTICS Corp); STEEP · HIGH-MED vs this page's MID · PEAK · ELITE-MED.
US Foods Holding Corp. · PEAK

ABS(ceo_total_comp) peer at $18.1M (Δ $62K heavier vs UNITED THERAPEUTICS Corp); STEEP · HIGH-MED vs this page's MID · PEAK · ELITE-MED.
Lantheus Holdings, Inc. (SIC 28 pole)

Lantheus Holdings, Inc. stamps MID · PEAK nearest in-SIC by ABS(pay_ratio) to UNITED THERAPEUTICS Corp's MID filing.
National dual ranks · #206/#793

UNITED THERAPEUTICS Corp's FY2025 package sits #206 by CEO dollars and #793 by ratio under PEAK · MID.
Comp structure · PEAK

UNITED THERAPEUTICS Corp's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for UNITED THERAPEUTICS Corp (CIK 1082554), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.